Home › Research › Long-term cohort studies
Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study
Xiao T, van Kleef LA, Ikram MK, de Knegt RJ, Ikram MA.. Neurology, 2022-05-26
Topic: Risk, prevention and care in population studies
Plain-language summary
Background and objectives Nonalcoholic fatty liver disease (NAFLD) might affect brain health via the so-called liver-brain axis. Whether this results in an increased risk for dementia remains unclear. Therefore, we investigated the association of NAFLD and fibrosis with incident dementia and cognition among the elderly.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 3,975 participants. This prospective cohort study within the Rotterdam Study investigated whether nonalcoholic fatty liver disease and fibrosis are associated with incident dementia and cognition in elderly people. Reported effect size: HR 0.92; HR 1.07; HR 0.48.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xiao, T., van Kleef, L. A., Ikram, M. K., de Knegt, R. J., & Ikram, M. A. (2022). Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study. Neurology. https://doi.org/10.1212/wnl.0000000000200770
Vancouver
Xiao T, van Kleef LA, Ikram MK, de Knegt RJ, Ikram MA. Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study. Neurology. 2022. doi:10.1212/wnl.0000000000200770. PMID: 35618435.
BibTeX
@article{xiao2022-35618435,
author = {Xiao, T. and van Kleef, L. A. and Ikram, M. K. and de Knegt, R. J. and Ikram, M. A.},
title = {{Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study}},
journal = {Neurology},
year = {2022},
doi = {10.1212/wnl.0000000000200770},
pmid = {35618435},
url = {https://doi.org/10.1212/wnl.0000000000200770}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Whether this results in an increased risk for dementia remains unclear.
- Therefore, we investigated the association of NAFLD and fibrosis with incident dementia and cognition among the elderly.
- Methods We performed longitudinal and cross-sectional analyses within the Rotterdam Study, an ongoing prospective cohort.
- Participants visiting between 1997 and 2002 with available fatty liver index (FLI) (set 1) or participants visiting between 2009 and 2014 with abdominal ultrasound (set 2) and liver stiffness (set 3) were included.
Why it matters
This prospective cohort study within the Rotterdam Study investigated whether nonalcoholic fatty liver disease and fibrosis are associated with incident dementia and cognition in elderly people. It is observational, so it cannot prove that treating liver disease would prevent dementia.
Study details
- Study designprospective cohort
- Participants3,975
- Effect sizeHR 0.92; HR 1.07; HR 0.48
- Evidence strengthModerate
How this study scored 67/100
Published in a leading specialty journal, and it is a prospective cohort study, followed forward from enrollment. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A prospective cohort study, followed forward from enrollment |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 3 / 4 | 3,975 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 59 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.8 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 3 / 6 | Cited 7.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 39 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author M. Arfan Ikram: h-index 167 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35618435) |
| Free to read | 2 / 2 | Free to read |
| Total | 67 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.